Search results
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
WFTV 9 Orlando· 5 days agoThe CDC and the U.S. Food and Drug Administration...decide whether to be vaccinated. More than 10...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 2 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says
MedPage Today· 4 days ago...VAERS) revealed that there were 1.5 reports of GBS per 1 million doses administered of the GSK RSV vaccine (Arexvy), and 5 reports per 1 million doses administered of the Pfizer RSV vaccine (Abrysvo), according to researchers led by Anne Hause, PhD, of the CDC's National Center for Emerging and...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 1 day agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 1 day agoThe vaccine's efficacy is reported at 79% on the label, slightly lower than the 84% previously...
FDA approves Moderna's RSV vaccine, its second marketed product
USA TODAY via Yahoo News· 4 days agoModerna says it expects the shot to be available...patients in the U.S. by the fall vaccination season. A positive CDC decision from the agency will allow Moderna to compete ...